My watch list
my.bionity.com  
Login  

89 Current news from israel

rss
matching the following criteria

'Seeing' bodies with sound (no sight required)

10-03-2014

People born unable to see are readily capable of learning to perceive the shape of the human body through soundscapes that translate images into sound, according to researchers who report their findings in the Cell Press journal Current Biology on March 6. With a little training, soundscapes ...

more

image description
New hope for Gaucher patients

21-01-2014

What causes brain damage and inflammation in severe cases of Gaucher disease? Little is known about the events that lead to brain pathology in some forms of the disease, and there is currently no treatment available – a bleak outlook for sufferers and their families. Now, scientists at the ...

more

Merck Invests in Research Partnerships in Israel to Boost Innovation

02-12-2013

Merck is increasingly counting on partnerships with Israeli biotech companies, as demonstrated by its cooperation with Metabomed and ChanBio, both of which joined the Merck Serono Israel Bioincubator now. Merck is already cooperating with multiple Israeli start-up companies such as Qlight ...

more

Not so dumb

A new kind of genetic switch can target the activities of just one type of brain cell

27-11-2013

Mysterious brain cells called microglia are starting to reveal their secrets thanks to research conducted at the Weizmann Institute of Science. Until recently, most of the glory in brain research went to neurons. For more than a century, these electrically excitable cells were believed to perform ...

more

D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator

18-10-2013

D-Pharm Ltd announced receipt of approval from the regulatory authorities in the Ukraine to commence a Phase IIa clinical study of THR-18, to be given with the clot buster drug tissue plasminogen activator (tPA), in patients with acute ischemic stroke. THR-18 is a synthetic therapeutic peptide ...

more

New allosteric inhibitors of cholesterol synthesis – an alternative to statins?

29-08-2013

Researchers in Israel have identified a new catalytic anti-oxidant that could be a promising alternative to statins – the most prescribed cholesterol-lowering drugs in the world. Statins reduce cholesterol levels in the body by acting as competitive inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA ...

more

Evogene reports first quarter 2013 financial results

14-05-2013

Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...

more

'Traffic' in our cells works both for and against us

06-05-2013

A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells ...

more

BGU researchers have discovered how prolonged exposure to stress can increase the risk of autoimmune diseases

03-05-2013

Ben-Gurion University of the Negev researchers have proven that chronic stress increases the susceptibility to an autoimmune disease similar to multiple sclerosis, which is characterized by damage to the nervous system in the brain. The researchers, Dr. Idan Harpaz and Prof. Alon Monsonego, in ...

more

Researchers from BGU have generated a promising drug candidate for the treatment of Psoriasis

27-02-2013

Researchers from the Department of Life Sciences and the National Institute for Biotechnology in the Negev at Ben-Gurion University of the Negev in collaboration with Teva pharmaceutical industries LTD. have engineered a natural immune system receptor into a promising drug candidate for the ...

more

Page 1 From 9
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE